A Research Study To Test How Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given By Subcutaneous Injection (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)

NCT02766647 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Neutropenia (Low White Blood Cell Count)

Interventions

BIOLOGICAL: Filgrastim Hospira (US)
BIOLOGICAL: US-approved Neupogen®

Sponsor

Pfizer

Collaborators

[object Object]